The Company is advancing clinical programs, including trials of HG004 (granted ODD & RPDD by FDA) LIGHT trial (NCT06088992) and Phase 1/2 international, master-protocol STAR clinical trial (NCT05906953) for RPE65 -associated retinal disease, HG202 RNA-editing therapy SIGHT-I first-in-human trial (NCT06031727) and BRIGHT Phase 1 clinical trial (NCT06623279) for nAMD, HG204 RNA-editing therapy (granted ODD & RPDD by FDA and ODD by EMA) HERO trial (NCT06615206) for MECP2 duplication syndrome, and HG302 DNA-editing therapy (granted ODD & RPDD by FDA) first-in-human MUSCLE trial (NCT06594094) for DMD
Phase II Metabolism: Phase II metabolites are highly polar and water-soluble conjugates formed by the addition of endogenous molecules
DuJWangTLiYZhouYWangXYuXet alDHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin
They will usually take about 1/2 of a pump easily
Declan Culliton The Sensational Country Blues Wonders
Other symptoms of beriberi include: cardiovascular symptoms, including an enlarged heart or tachycardia difficulty breathing muscle weakness seizures vomiting anorexia swelling Who is at risk of B1 deficiency